Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 178

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients

Parnetti, Lucilla, Paciotti, Silvia, Eusebi, Paolo, Dardis, Andrea, Zampieri, Stefania, Chiasserini, Davide, Tasegian, Anna, Tambasco, Nicola, Bembi, Bruno, Calabresi, Paolo, Beccari, Tommaso · 2017 · Movement Disorders

Abstract

Background: Reduced β‐glucocerebrosidase activity was observed in postmortem brains of both GBA1 mutation carrier and noncarrier Parkinson's disease patients, suggesting that lower β‐glucocerebrosidase activity is a key feature in the pathogenesis of PD. The objectives of this study were to confirm whether there is reduced β‐glucocerebrosidase activity in the CSF of GBA1 mutation carrier and noncarrier PD patients and verify if other lysosomal enzymes show altered activity in the CSF. Methods: CSF β‐glucocerebrosidase, cathepsin D, and β‐hexosaminidase activities were measured in 79 PD and 61 healthy controls from the BioFIND cohort. The whole GBA1 gene was sequenced. Results: Enzyme activities were normalized according to CSF protein content (specific activity). β‐glucocerebrosidase specific activity was significantly decreased in PD versus controls (‐28%, P < 0.001). GBA1 mutations were found in 10 of 79 PD patients (12.7%) and 3 of 61 controls (4.9%). GBA1 mutation carrier PD patients showed significantly lower β‐glucocerebrosidase specific activity versus noncarriers. β‐glucocerebrosidase specific activity was also decreased in noncarrier PD patients versus controls (‐25%, P < 0.001). Cathepsin D specific activity was lower in PD versus controls (‐21%, P < 0.001). β‐Hexosaminidase showed a similar trend. β‐Glucocerebrosidase specific activity fairly discriminated PD from controls (area under the curve, 0.72; sensitivity, 0.67; specificity, 0.77). A combination of β‐glucocerebrosidase, cathepsin D, and β‐hexosaminidase improved diagnostic accuracy (area under the curve, 0.77; sensitivity, 0.71; specificity, 0.85). Lower β‐glucocerebrosidase and β‐hexosaminidase specific activities were associated with worse cognitive performance. Conclusions: CSF β‐glucocerebrosidase activity is reduced in PD patients independent of their GBA1 mutation carrier status. Cathepsin D and β‐hexosaminidase were also decreased. The possible link between altered CSF lysosomal enzyme activities and cognitive decline deserves further investigation. © 2017 International Parkinson and Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.27136

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 178

Metadata

Authors
Parnetti, L., Paciotti, S., Eusebi, P., Dardis, A., Zampieri, S., Chiasserini, D., Tasegian, A., Tambasco, N., Bembi, B., Calabresi, P., & Beccari, T.
Venue
Movement Disorders
Publisher
Wiley
Published
2017-08-26
Volume
32
Issue
10
Pages
1423-1431
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2749037114
Cited by
178
References
3
FWCI
13.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients. https://app.cochat.ai/papers/10.1002/mds.27136
The paper
Parnetti, L., Paciotti, S., Eusebi, P., Dardis, A., Zampieri, S., Chiasserini, D., Tasegian, A., Tambasco, N., Bembi, B., Calabresi, P., & Beccari, T. (2017). Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients. Movement Disorders. https://doi.org/10.1002/mds.27136

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.